BPG is committed to discovery and dissemination of knowledge
Featured Articles
3/2/2016 10:36:00 AM | Browse: 616 | Download: 1454
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 21268
Country Germany
ISSN 1948-5204 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Radiology, Nuclear Medicine & Medical Imaging
Manuscript Type Review
Article Title Neoadjuvant radiotherapeutic strategies in pancreatic cancer
Manuscript Source Invited Manuscript
All Author List Falk Roeder
Funding Agency and Grant Number
Corresponding Author Dr. Falk Roeder, PhD, Department of Radiation Oncology, University Hospital of Munich (LMU), Marchioninistr 15, 81377 Munich, Germany. falk.roeder@med.uni-muenchen.de
Key Words Pancreatic cancer; Neoadjuvant; Radiation therapy; Review; Radiation techniques
Core Tip This review summarizes the current status of neoadjuvant radiation approaches for pancreatic cancer. Neoadjuvant chemoradiation for locally-advanced cases results in secondary resectability in a substantial proportion of patients with consecutively improved overall prognosis. In resectable pancreatic cancer, outstanding results in terms of response, local control and overall survival have been observed in several phaseⅠ/Ⅱ trials. Further investigation of neoadjuvant chemoradiation strategies should be performed preferentially in randomized trials and included evaluation of optimal sequencing with chemotherapy and patient selection based on molecular markers. Modern radiation techniques widen the therapeutic window and contribute to the reduction of toxicity.
Publish Date 2016-02-02 18:35
Citation Roeder F. Neoadjuvant radiotherapeutic strategies in pancreatic cancer. World J Gastrointest Oncol 2016; 8(2): 186-197
URL http://www.wjgnet.com/1948-5204/full/v8/i2/186.htm
DOI http://dx.doi.org/10.4251/wjgo.v8.i2.186
Full Article (PDF) WJGO-8-186.pdf
Full Article (Word) WJGO-8-186.doc